Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LICORN
2012-000232-25Phase 3Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Aug 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of levosimendan in coronary arteriosclerosis, sponsored by Assistance publique - Hôpitaux de Paris. Started Aug 2012; status: completed.
02
Drugs
levosimendan
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on 2012-000232-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-000232-25.